Related Experiment Video
Updated: Dec 26, 2025

Implementing Patch Clamp and Live Fluorescence Microscopy to Monitor Functional Properties of Freshly Isolated PKD Epithelium
Published on: September 1, 2015
APOL1 C-Terminal Variants May Trigger Kidney Disease through Interference with APOL3 Control of Actomyosin
Sophie Uzureau1, Laurence Lecordier1, Pierrick Uzureau2
1Laboratory of Molecular Parasitology, IBMM, Université Libre de Bruxelles, 6041 Gosselies, Belgium.
Abstract:
The C-terminal variants G1 and G2 of apolipoprotein L1 (APOL1) confer human resistance to the sleeping sickness parasite Trypanosoma rhodesiense, but they also increase the risk of kidney disease. APOL1 and APOL3 are death-promoting proteins that are partially associated with the endoplasmic reticulum and Golgi membranes. We report that in podocytes, either APOL1 C-terminal helix truncation (APOL1Δ) or APOL3 deletion (APOL3KO) induces similar actomyosin reorganization linked to the inhibition of phosphatidylinositol-4-phosphate [PI(4)P] synthesis by the Golgi PI(4)-kinase IIIB (PI4KB). Both APOL1 and APOL3 can form K+ channels, but only APOL3 exhibits Ca2+-dependent binding of high affinity to neuronal calcium sensor-1 (NCS-1), promoting NCS-1-PI4KB interaction and stimulating PI4KB activity. Alteration of the APOL1 C-terminal helix triggers APOL1 unfolding and increased binding to APOL3, affecting APOL3-NCS-1 interaction. Since the podocytes of G1 and G2 patients exhibit an APOL1Δ or APOL3KO-like phenotype, APOL1 C-terminal variants may induce kidney disease by preventing APOL3 from activating PI4KB, with consecutive actomyosin reorganization of podocytes.
Insights
Apolipoprotein L1 (APOL1) variants linked to kidney disease risk disrupt podocyte function by inhibiting PI4KB, a key enzyme in lipid synthesis. This leads to actomyosin reorganization and potential kidney damage.
Area of Science:
- Cell Biology
- Molecular Biology
- Nephrology
Background:
- Apolipoprotein L1 (APOL1) C-terminal variants (G1, G2) confer resistance to Trypanosoma rhodesiense but increase kidney disease risk.
- APOL1 and APOL3 are death-promoting proteins associated with the endoplasmic reticulum and Golgi membranes.
Purpose of the Study:
- To investigate the molecular mechanisms by which APOL1 variants and APOL3 affect podocyte function.
- To elucidate the role of phosphatidylinositol-4-phosphate (PI(4)P) synthesis and actomyosin organization in APOL1-associated nephropathy.
Main Methods:
- Studied APOL1 C-terminal helix truncation (APOL1Δ) and APOL3 deletion (APOL3KO) in podocytes.
- Assessed actomyosin reorganization, PI(4)P synthesis, and protein interactions involving APOL1, APOL3, calcium, and NCS-1.
Main Results:
- Both APOL1Δ and APOL3KO induced similar actomyosin reorganization linked to inhibited PI(4)P synthesis by PI4KB.
- APOL3, but not APOL1, binds NCS-1 in a Ca2+-dependent manner, promoting PI4KB activity.
- APOL1 C-terminal helix alteration increased APOL1 binding to APOL3, impairing APOL3-NCS-1 interaction.
Conclusions:
- APOL1 C-terminal variants may cause kidney disease by preventing APOL3 from activating PI4KB, leading to podocyte actomyosin reorganization.
- The findings link APOL1 nephropathy to dysregulated PI4KB activity and cytoskeletal changes in podocytes.
Related Concept Videos
Actin Polymerization and Cell Motility
Actin cytoskeleton dynamics can produce pushing, pulling, and resistance forces that help the cell to migrate....
Nephrons
Acute Kidney Injury II: Pathophysiology
Allosteric Proteins-ATCase
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
External Anatomy of the Kidney
The kidneys are located in the retroperitoneal space on either side of the vertebral column, protected posteriorly by the 11th and 12th ribs. The right kidney sits slightly lower than the left owing to the presence of the liver...
Cytoskeletal Linker Proteins - Plakins

